Today, the European Medicines Agency (EMA) will hold an online event to explain the processes for the development, evaluation, approval and safety monitoring of COVID-19 vaccines in the EU, including EMA’s specific role.
It will also give the opportunity to the public and stakeholder groups to speak and share their needs, expectations and any concerns, that will be considered by EMA and the European medicines regulatory network in the decision-making process. The event will start at 13:00 CET and can be followed online.
More information is available on the new Commission website on safe and effective vaccination in the EU. In particular, learn about how vaccines work, the health benefits of vaccines, the authorisation process, their long-term safety and the EU’s current portfolio.
*Source: European Commission
By: N. Peter Kramer
